CVS Health Q1 2025 Filing: Financial Snapshot
Ticker: CVS · Form: 10-Q · Filed: 2025-05-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
**CVS Health Q1 2025: Financials released, check the balance sheet.**
AI Summary
CVS Health Corp. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing details its financial performance, including revenue from products and services, and its balance sheet as of March 31, 2025, compared to December 31, 2024, and March 31, 2024.
Why It Matters
This 10-Q filing provides investors with a detailed look at CVS Health's financial health and operational performance during the first quarter of 2025, influencing investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information.
Key Numbers
- 2025-03-31 — Balance Sheet Date (End of Q1 2025)
- 2024-12-31 — Previous Balance Sheet Date (End of Q4 2024)
- 2024-03-31 — Prior Year Balance Sheet Date (End of Q1 2024)
Key Players & Entities
- CVS HEALTH Corp (company) — Filer
- 20250331 (date) — Period of Report
- 20250501 (date) — Filed as of Date
- 0000064803 (company) — Central Index Key
- RI (location) — State of Incorporation
- DE (location) — State of Incorporation
FAQ
What were CVS Health's total revenues for products in Q1 2025?
The filing indicates revenues from products for the period January 1, 2025 to March 31, 2025.
What were CVS Health's total revenues for services in Q1 2025?
The filing indicates revenues from services for the period January 1, 2025 to March 31, 2025.
What is the company's Central Index Key (CIK)?
The CIK for CVS Health Corp. is 0000064803.
When was the period of report for this 10-Q filing?
The period of report was March 31, 2025.
What is the fiscal year end for CVS Health Corp.?
The fiscal year end for CVS Health Corp. is December 31.
From the Filing
0000064803-25-000013.txt : 20250501 0000064803-25-000013.hdr.sgml : 20250501 20250501063546 ACCESSION NUMBER: 0000064803-25-000013 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 25899216 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 10-Q 1 cvs-20250331.htm 10-Q cvs-20250331 0000064803 12/31 2025 Q1 false http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember xbrli:shares iso4217:USD iso4217:USD xbrli:shares cvs:store cvs:clinic cvs:people cvs:patient cvs:segment cvs:program cvs:security xbrli:pure cvs:lease cvs:state cvs:claim 0000064803 2025-01-01 2025-03-31 0000064803 2025-04-23 0000064803 us-gaap:ProductMember 2025-01-01 2025-03-31 0000064803 us-gaap:ProductMember 2024-01-01 2024-03-31 0000064803 2024-01-01 2024-03-31 0000064803 us-gaap:ServiceMember 2025-01-01 2025-03-31 0000064803 us-gaap:ServiceMember 2024-01-01 2024-03-31 0000064803 2025-03-31 0000064803 2024-12-31 0000064803 2023-12-31 0000064803 2024-03-31 0000064803 us-gaap:CommonStockMember 2024-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2024-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-12-31 0000064803 us-gaap:RetainedEarningsMember 2024-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000064803 us-gaap:ParentMember 2024-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2024-12-31 0000064803 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000064803 us-gaap:ParentMember 2025-01-01 2025-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000064803 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000064803 us-gaap:CommonStockMember 2025-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2025-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-03-31 0000064803 us-gaap:RetainedEarningsMember 2025-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000064803 us-gaap:ParentMember 2025-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2025-03-31 0000064803 us-gaap:CommonStockMember 2023-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2023-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0000064803 us-gaap:RetainedEarningsMember 2023-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000064803 us-gaap:ParentMember 2023-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2023-12-31 0000064803 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000064803 us-gaap:ParentMember 2024-01-01 2024-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000064803 us-gaap:TreasuryStockCommonMemb